🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of Tylenol, alleging the firms hid safety concerns that the medication posed to children's neurological development.

The court filing follows a month after President Donald Trump publicized an unproven link between using acetaminophen - alternatively called paracetamol - during pregnancy and autism spectrum disorder in young ones.

The attorney general is suing Johnson & Johnson, which formerly manufactured the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "deceived the public by making money from discomfort and promoting medication ignoring the dangers."

The manufacturer asserts there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening countless individuals to increase profits," the attorney general, from the Republican party, said.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the safety of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its official site, the company also mentioned it had "continuously evaluated the pertinent research and there is insufficient valid information that demonstrates a established connection between taking acetaminophen and autism."

Organizations speaking for doctors and medical practitioners agree.

The leading OB-GYN organization has said paracetamol - the key substance in acetaminophen - is one of the few options for pregnant women to address discomfort and elevated temperature, which can create significant medical dangers if left untreated.

"In multiple decades of studies on the consumption of acetaminophen in gestation, not a single reputable study has definitively established that the use of paracetamol in any trimester of gestation causes neurological conditions in children," the association stated.

This legal action cites recent announcements from the former administration in asserting the medication is potentially dangerous.

Last month, Trump caused concern from medical authorities when he told women during pregnancy to "struggle intensely" not to take Tylenol when ill.

Federal regulators then issued a notice that medical professionals should consider limiting the use of Tylenol, while also stating that "a proven link" between the drug and autism in young ones has not been proven.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had vowed in April to conduct "comprehensive study program" that would identify the origin of autism spectrum disorder in a short period.

But experts cautioned that finding a single cause of autism spectrum disorder - believed by scientists to be the result of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism is a type of permanent neurological difference and condition that affects how individuals perceive and interact with the environment, and is recognized using medical professional evaluations.

In his lawsuit, the attorney general - a Trump ally who is running for federal office - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the science" around paracetamol and autism spectrum disorder.

The case seeks to make the companies "destroy any commercial messaging" that asserts Tylenol is reliable for pregnant women.

The Texas lawsuit parallels the concerns of a collection of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the manufacturers of Tylenol in recently.

The court dismissed the legal action, saying investigations from the plaintiffs' authorities was lacking definitive proof.